Overlapping Molecular Pathways Leading to Autism Spectrum Disorders, Fragile X Syndrome, and Targeted Treatments.

Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Maria Jimena Salcedo-ArellanoRandi J Hagerman

Abstract

Autism spectrum disorders (ASD) are subdivided into idiopathic (unknown) etiology and secondary, based on known etiology. There are hundreds of causes of ASD and most of them are genetic in origin or related to the interplay of genetic etiology and environmental toxicology. Approximately 30 to 50% of the etiologies can be identified when using a combination of available genetic testing. Many of these gene mutations are either core components of the Wnt signaling pathway or their modulators. The full mutation of the fragile X mental retardation 1 (FMR1) gene leads to fragile X syndrome (FXS), the most common cause of monogenic origin of ASD, accounting for ~ 2% of the cases. There is an overlap of molecular mechanisms in those with idiopathic ASD and those with FXS, an interaction between various signaling pathways is suggested during the development of the autistic brain. This review summarizes the cross talk between neurobiological pathways found in ASD and FXS. These signaling pathways are currently under evaluation to target specific treatments in search of the reversal of the molecular abnormalities found in both idiopathic ASD and FXS.

References

May 1, 1988·American Journal of Medical Genetics·R J HagermanM D Wittenberger
Mar 1, 1980·Journal of Autism and Developmental Disorders·E SchoplerK Daly
Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·P McCaffery, U C Dräger
Feb 15, 1996·Archives of Biochemistry and Biophysics·X Q XuG Romero
Jan 1, 1996·Annual Review of Genetics·M Hochstrasser
Apr 1, 1997·Anesthesiology·B A OrserJ F MacDonald
Sep 1, 1997·Nature Genetics·T H Vu, A R Hoffman
Oct 24, 1997·Annals of Neurology·D C ChuganiH T Chugani
Feb 13, 2002·American Journal of Medical Genetics·Yujun ShaoMargaret A Pericak-Vance
Jun 11, 2002·Annual Review of Nutrition·Margaret Clagett-Dame, Hector F DeLuca
Dec 24, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Eric HollanderSerge Mosovich
Dec 18, 2003·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Manuel F CasanovaJuan Gomez
Apr 23, 2004·Trends in Biochemical Sciences·Richard S Jope, Gail V W Johnson
Jul 9, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Tomasz Schneider, Ryszard Przewłocki
Aug 18, 2004·Genes & Development·Nissim Hay, Nahum Sonenberg
Nov 4, 2004·Clinical Genetics·S U PetersC A Bacino
May 20, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Mei QinCarolyn Beebe Smith
Jun 2, 2005·Trends in Neurosciences·Alfonso Represa, Yehezkel Ben-Ari
Oct 18, 2005·Nature Medicine·Volodymyr I DzhalaKevin J Staley
May 16, 2006·American Journal of Medical Genetics. Part a·Deborah D HattonPenny Mirrett
Sep 29, 2006·The New England Journal of Medicine·Peter B CrinoElizabeth Petri Henske
Nov 7, 2006·IUBMB Life·Zhimin Lu, Shuichan Xu
Dec 21, 2006·Journal of Autism and Developmental Disorders·Jane E RobertsWalter E Kaufmann
Apr 17, 2007·Journal of Developmental and Behavioral Pediatrics : JDBP·Stephen T NowickiRandi J Hagerman
Aug 1, 2007·Journal of Consulting and Clinical Psychology·Deborah K AndersonAndrew Pickles
Apr 25, 2008·Nature Reviews. Cancer·Alexandra Klaus, Walter Birchmeier
Jun 24, 2008·Nature Medicine·Dan EhningerAlcino J Silva
Aug 14, 2008·Journal of Developmental and Behavioral Pediatrics : JDBP·Elizabeth Berry-KravisWilliam T Greenough
Jan 2, 2009·Pediatrics·Randi J HagermanMichael Tranfaglia
Jan 9, 2009·American Journal of Mental Retardation : AJMR·Susan W HarrisRandi J Hagerman
Mar 21, 2009·Journal of Neuroscience Research·Elizabeth R WhitneyGene J Blatt
Apr 3, 2009·The Journal of Clinical Investigation·Pat Levitt, Daniel B Campbell

❮ Previous
Next ❯

Citations

Jul 20, 2021·Frontiers in Integrative Neuroscience·María GamarraJimena Baleriola

❮ Previous
Next ❯

Software Mentioned

VANILLA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.